We use cookies in order to provide you with a user-friendly and effective service as well as content adapted to your interests. We also use cookies to dynamically display Univadis ads and ads from our business partners on both Univadis and selected third party websites. By clicking or navigating the site, you agree to this use. Manage preferences.Läs mer.
Prof Andrew Owen discussed some of the models used in drug development for SARS-CoV-2 and asked what we can learn from targeting other viruses including HIV.
Prof Amanda Mocroft presented data from the RESPOND study on the effects of CD4 and viral load on smoking-related cancer incidence in people living with HIV (PLWH).
Univadis - en service från MSD
